Science, engineering, and discovery — the research and breakthroughs that matter.

From old-school stars to young upstarts, the birthplace of hip-hop is basking in the big moment.

The next phase of the Second Avenue subway, first proposed in the 1920s, could finally be completed by 2032, creating a new transit hub in Harlem.

Colleges from North Dakota to New Jersey are trying to get students to sign up for A.I. degrees. What they teach varies widely.

Revolution and Tango yield promising cancer results, Incyte buys bleeding disorder drug, and more biotech news

As the war in Iran persists, signs point to a prolonged period of higher prices and slower growth rather than a quick shock.

Nithya Raman pulled into second place in the race to see who will face Mayor Karen Bass in November. There are more votes to be counted.

Mexicans are enraged after viral videos claimed Adidas exploited Indigenous women to sew World Cup jerseys. We traveled into the mountains to speak to the artisans themselves.

Many Democrats are sticking by their presumptive Senate nominee Graham Platner. But some have soured, and others are anxious about how recent revelations could affect a close race.

OpenEvidence, a fast-growing start-up, is using artificial intelligence to help doctors find answers to clinical questions for diagnosis and treatment.

A crowd that included Daniel Radcliffe, Cole Escola and Carrie Coon celebrated with whiskey ice cream at Rockefeller Center and show tunes at the Carlyle hotel.

Don’t let childhood memories of mealtime standoffs turn you away from these nutritional powerhouses.

Lilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutide

The Iran war is pushing countries to prioritize domestic energy in order to protect themselves from volatile oil and natural gas markets.

The Gulf hub model was built for scale and transfer traffic. The Iran war has disabled both.

Johnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.

Four years to scale to 550 aircraft and 200 million passengers. Four years to build a widebody business while Air India races down the same long-haul runway. The clock is ticking for IndiGo.